Muscle & Nerve · 1981 · 114 citations · 44 references
MedicineNeurologyNeuroscienceElectrophysiologyNeuromuscular DisordersNeuropathologyCholinergic NeurochemistryCholinergic PharmacologyCongenital Myasthenic SyndromesMuscle DisordersMuscle PathologyNeuromuscular JunctionAcetylcholine Receptor DefectsEndplate Structural AbnormalitiesIntercostal MusclesMiniature Endplate PotentialsPostsynaptic Congenital Myasthenic SyndromesPostsynaptic DysfunctionPresynaptic Congenital Myasthenic SyndromesReceptors
The nature of the defect in congenital myasthenia was investigated in biopsy specimens of intercostal muscle from 5 male patients whose symptoms presented between birth and 2 years of age. Miniature end-plate potentials were reduced in amplitude in all 5 patients. The number of acetylcholine receptors as determined by alpha-bungarotoxin binding was normal in case 1 and reduced in cases, 2, 4, and 5. The shape of the end-plates as shown by autoradiography and cholinesterase staining was normal in case 1 and elongated in cases 2, 4, and 5. In cases 3, alpha-bungarotoxin binding was slowly reversible, and there were some muscle fibers with multiple end-plate regions. The acetylcholine content of the muscle was normal in all 5 cases. None of the patients had serum antibody to human acetylcholine receptor as measured by immunoprecipitation or inhibition of alpha-bungarotoxin binding. We conclude that congenital myasthenia is a heterogeneous condition of nonimmune etiology in which both presynaptic and postsynaptic defects can be found.
44
Antibody to acetylcholine receptor in myasthenia gravis
Jon Lindstrom, Marjorie E. Seybold, Vanda A. Lennon et al. · Neurology · 1976 · 1.2K citations · Full text
Life Sciences, Immunology, Neurology +12